Accessibility Menu
 
Co-Diagnostics logo

Co-Diagnostics

(NASDAQ) CODX

Current Price$1.78
Market Cap$4.23M
Since IPO (2017)-99%
5 Year-99%
1 Year-85%
1 Month-26%

Co-Diagnostics Financials at a Glance

Market Cap

$4.23M

Revenue (TTM)

$507.89K

Net Income (TTM)

$32.18M

EPS (TTM)

$-28.73

P/E Ratio

-0.07

Dividend

$0.00

Beta (Volatility)

1.25 (Average)

Price

$1.78

Volume

388,319

Open

$1.90

Previous Close

$1.75

Daily Range

$1.66 - $1.95

52-Week Range

$1.66 - $46.50

CODX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Co-Diagnostics

Industry

Healthcare Equipment and Supplies

Employees

132

CEO

Dwight Howard Egan

Website

co-dx.com

Headquarters

Salt Lake City, UT 84109, US

CODX Financials

Key Financial Metrics (TTM)

Gross Margin

34%

Operating Margin

-70%

Net Income Margin

-63%

Return on Equity

-62%

Return on Capital

-87%

Return on Assets

-72%

Earnings Yield

-14.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.23M

Shares Outstanding

2.10M

Volume

388.32K

Short Interest

0.00%

Avg. Volume

2.77M

Financials (TTM)

Gross Profit

$2.92M

Operating Income

$40.08M

EBITDA

$38.70M

Operating Cash Flow

$29.16M

Capital Expenditure

$748.35K

Free Cash Flow

$29.90M

Cash & ST Invst.

$29.75M

Total Debt

$2.15M

Co-Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$145.38K

-77.3%

Gross Profit

$119.09K

-65.4%

Gross Margin

81.92%

N/A

Market Cap

$4.23M

N/A

Market Cap/Employee

$32.06K

N/A

Employees

132

N/A

Net Income

$5.89M

+39.3%

EBITDA

$6.75M

+31.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$9.97M

-71.7%

Accounts Receivable

$979.12K

+449.3%

Inventory

$1.09M

-13.9%

Long Term Debt

$727.94K

-50.6%

Short Term Debt

$744.16K

-17.0%

Return on Assets

-71.93%

N/A

Return on Invested Capital

-86.56%

N/A

Free Cash Flow

$5.98M

+19.2%

Operating Cash Flow

$5.90M

+18.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DWTXDogwood Therapeutics, Inc.
$1.98-4.81%
XAIRBeyond Air, Inc.
$0.72+4.68%
TNONTenon Medical, Inc.
$0.70-4.66%
ALURAllurion Technologies Inc.
$0.77-6.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About CODX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.